Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 29, Number 10—October 2023
Research

Characteristics of and Deaths among 333 Persons with Tuberculosis and COVID-19 in Cross-Sectional Sample from 25 Jurisdictions, United States

Scott A. NabityComments to Author , Suzanne M. Marks, Neela D. Goswami, Shona R. Smith, Evan Timme, Sandy F. Price, Lon Gross, Julie L. Self, Katelynne Gardner Toren, Masahiro Narita, Donna H. Wegener, Shu-Hua Wang, and for the National Tuberculosis Controllers Association/CDC TB-COVID-19 Collaboration1
Author affiliations: California Department of Public Health, Richmond, California, USA (S.A. Nabity); Centers for Disease Control and Prevention, Atlanta, USA (S.A. Nabity, S.M. Marks, N.D. Goswami, S.F. Price, L. Gross, J.L. Self); Michigan Department of Health and Human Services, Lansing, Michigan, USA (S.R. Smith); Arizona Department of Health Services, Phoenix, Arizona, USA (E. Timme); Public Health–Seattle & King County, Seattle, Washington, USA (K. Gardner Toren, M. Narita); University of Washington, Seattle (M. Narita); National Tuberculosis Controllers Association, Atlanta (D.H. Wegener); The Ohio State University College of Medicine, Columbus, Ohio, USA (S.-H. Wang)

Main Article

Figure 1

Analytic sample selection for persons with TB and COVID-19 co-diagnosed within 180 days (TB–COVID-19), 26 US jurisdictions, 2020. Three states performed registry matches with COVID-19 data up-to-date through an earlier date (January 24, 2021; February 2, 2021; August 31, 2021); 1 US state (North Dakota) that participated did not have TB–COVID-19 cases. The number of days between TB and COVID-19 diagnosis dates was calculated without regard for which disease was diagnosed first. Data from 2 jurisdictions (Puerto Rico and Los Angeles County; remainder of California included) were excluded because of incompleteness of outcomes data. TB, tuberculosis.

Figure 1. Analytic sample selection for persons with TB and COVID-19 co-diagnosed within 180 days (TB–COVID-19), 26 US jurisdictions, 2020. Three states performed registry matches with COVID-19 data up-to-date through an earlier date (January 24, 2021; February 2, 2021; August 31, 2021); 1 US state (North Dakota) that participated did not have TB–COVID-19 cases. The number of days between TB and COVID-19 diagnosis dates was calculated without regard for which disease was diagnosed first. Data from 2 jurisdictions (Puerto Rico and Los Angeles County; remainder of California included) were excluded because of incompleteness of outcomes data. TB, tuberculosis.

Main Article

1Group members are listed at the end of this article.

Page created: August 08, 2023
Page updated: September 20, 2023
Page reviewed: September 20, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external